(Q37611862)

21 August 2017

1 reference

title

Therapeutic vaccination and novel strategies to treat chronic HBV infection (English)

1 reference

21 August 2017

Antonio Bertoletti

1

0 references

author name string

Adam Gehring

series ordinal

2

1 reference

21 August 2017

language of work or name

1 reference

1 October 2009

1 reference

Expert Review of Gastroenterology & Hepatology

21 August 2017

published in

1 reference

21 August 2017

volume

3

1 reference

21 August 2017

issue

5

1 reference

21 August 2017

page(s)

561-569

1 reference

Hepatitis B Virus Infection

21 August 2017

cites work

1 reference

Translation of immunological knowledge into better treatments of chronic hepatitis B.

21 January 2018

1 reference

Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B

21 January 2018

1 reference

Long-lasting memory T cell responses following self-limited acute hepatitis B

21 January 2018

1 reference

Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B.

21 January 2018

1 reference

The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis

21 January 2018

1 reference

Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen

21 January 2018

1 reference

Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection

21 January 2018

1 reference

Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire.

21 January 2018

1 reference

Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

21 January 2018

1 reference

Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B.

21 January 2018

1 reference

Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen

21 January 2018

1 reference

Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft

21 January 2018

1 reference

Immunization with surface antigen vaccine alone and after treatment with 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl)-uracil (L-FMAU) breaks humoral and cell-mediated immune tolerance in chronic woodchuck hepatitis virus infection

21 January 2018

1 reference

Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein.

21 January 2018

1 reference

Therapeutic vaccination of chronic hepatitis B patients with virus suppression by antiviral therapy: a randomized, controlled study of co-administration of HBsAg/AS02 candidate vaccine and lamivudine

21 January 2018

1 reference

Combination of an antiviral drug and immunomodulation against hepadnaviral infection in the woodchuck model

21 January 2018

1 reference

Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers

21 January 2018

1 reference

A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. The CY1899 T Cell Vaccine Study Group

21 January 2018

1 reference

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans

21 January 2018

1 reference

Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study

21 January 2018

1 reference

Dendritic cell-based therapies in the bench and the bedsides

21 January 2018

1 reference

A randomized controlled phase IIb trial of antigen-antibody immunogenic complex therapeutic vaccine in chronic hepatitis B patients

21 January 2018

1 reference

Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan.

21 January 2018

1 reference

Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine

21 January 2018

1 reference

Hepatitis B virus translocates across a trophoblastic barrier.

21 January 2018

1 reference

Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment

21 January 2018

1 reference

Molecular signature of CD8+ T cell exhaustion during chronic viral infection.

21 January 2018

1 reference

Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection

21 January 2018

1 reference

Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection

21 January 2018

1 reference

Profile of tumor antigen-specific CD8 T cells in patients with hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections

21 January 2018

1 reference

Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy

21 January 2018

1 reference

The serology of chronic hepatitis B infection revisited

21 January 2018

1 reference

Role of regulatory T cells in gastrointestinal inflammatory disease

21 January 2018

1 reference

Natural regulatory T cells and persistent viral infection

21 January 2018

1 reference

T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies.

21 January 2018

1 reference

Association of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and viral clearance in patients with hepatitis B.

21 January 2018

1 reference

Modulation of the CD8+-T-cell response by CD4+ CD25+ regulatory T cells in patients with hepatitis B virus infection

21 January 2018

1 reference

Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection.

21 January 2018

1 reference

Immunobiology of dendritic cells

21 January 2018

1 reference

In vitro and in vivo infectivity and pathogenicity of the lymphoid cell-derived woodchuck hepatitis virus

21 January 2018

1 reference

Phenotype and function of monocyte derived dendritic cells in chronic hepatitis B virus infection

21 January 2018

1 reference

Dendritic cells take up viral antigens but do not support the early steps of hepatitis B virus infection

21 January 2018

1 reference

Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B.

21 January 2018

1 reference

Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection

21 January 2018

1 reference

Genetic immunization of chimpanzees chronically infected with the hepatitis B virus, using a recombinant retroviral vector encoding the hepatitis B virus core antigen

21 January 2018

1 reference

Rational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections

21 January 2018

1 reference

Distinct, cross-reactive epitope specificities of CD8 T cell responses are induced by natural hepatitis B surface antigen variants of different hepatitis B virus genotypes

21 January 2018

1 reference

Synergistic Reversal of Intrahepatic HCV-Specific CD8 T Cell Exhaustion by Combined PD-1/CTLA-4 Blockade

21 January 2018

1 reference

Enhancing SIV-specific immunity in vivo by PD-1 blockade

21 January 2018

1 reference

The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection

21 January 2018

1 reference

T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes.

21 January 2018

1 reference

Cancer regression in patients after transfer of genetically engineered lymphocytes

21 January 2018

1 reference

Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors

21 January 2018

1 reference

Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers

21 January 2018

1 reference

Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation.

21 January 2018

1 reference

Clearance of hepatitis B surface antigen after bone marrow transplantation: Role of adoptive immunity transfer

21 January 2018

1 reference

Hepatitis B surface antigenemia at birth: A long-term follow-up study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/EGH.09.48

1 reference

21 August 2017

1 reference